论文信息 - Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial - 字舞流文

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

A. Wotherspoon | D. Cunningham | D. Ferry | T. Crosby | G. Middleton | I. Chau | Y. Barbáchano | C. Peckitt | J. Waters | J. Wadsley | T. Iveson | S. Falk | F. Coxon | S. Slater | T. Waddell | D. Gonzalez | A. Okines | C. Saffery | W. Mansoor | David B. Smith | David Gonzalez